Glipizide 5 mg Tablets — Generic For Glucotrol — TEVA

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Glipizide tablets are an oral blood-glucose-lowering medicine in the sulfonylurea class. The label says they are used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.

The tablets contain glipizide as the active ingredient. The label states that glipizide works by stimulating insulin release from the pancreas, and that blood sugar control may continue for up to 24 hours after a single dose in some patients.

Glipizide should not be used in people with type 1 diabetes mellitus or diabetic ketoacidosis. The label also warns that sulfonylureas can cause severe hypoglycemia and that certain medicines, alcohol, illness, missed meals, or heavy exercise can affect blood sugar control.

Storage Information

Store below 30°C (86°F). Dispense in a tight container as defined in the USP.

Key Counseling Points

• Take glipizide about 30 minutes before a meal, as directed on the label.
• Use it as an adjunct to diet and exercise; it is not a substitute for dietary management.
• Know the symptoms of hypoglycemia and be aware that severe low blood sugar can occur with sulfonylureas.
• Tell your healthcare provider about all medicines you take, since many drugs may increase or decrease glipizideu2019s effect.
• Blood and urine glucose should be monitored periodically; glycosylated hemoglobin may also be useful.
• If blood sugar control worsens during stress such as fever, trauma, infection, or surgery, the label says insulin may be needed.
• Report signs of liver injury, such as jaundice, because the label says glipizide should be discontinued if cholestatic or hepatocellular liver injury with jaundice occurs.
• If you are pregnant or nursing, the label says the benefits and risks should be considered carefully.
• Safety and effectiveness in children have not been established.

Helpful Patient Education

Glipizide tablets USP are an oral sulfonylurea medicine described in the DailyMed label as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus. The label notes that glipizide helps lower blood glucose by stimulating insulin release from the pancreas.

Educational label information also highlights important safety topics, including the risk of hypoglycemia, possible drug interactions, and the need for periodic blood and urine glucose monitoring. This product page information is intended to summarize the label in plain language for pharmacy education.

Medication Summary last generated: 2026-07-18 02:47:55